Stock Rich List
#183 on the corporate holders of 813 holders

Broadwood Capital INC

10% owner at STAAR Surgical; 10% owner at Lineage Cell Therapeutics; 10% owner at Insight Molecular Diagnostics.

$929M
in disclosed stock, −$10.5M (−1.11%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
183rd of 813
Companies held
3
Largest holding
STAA, 86.9% of total
Latest SEC filing
Apr 20, 2026
Listed but not counted
$408M

What the $929M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
STAAR Surgical STAA
Common Stock
Indirectly (see filing footnote)16,123,842$25.03$404M43.5%Form 4, Mar 13, 2026
STAAR Surgical STAA
Common Stock
Directly16,123,842$25.03$404M43.5%Form 4, Mar 13, 2026
Lineage Cell Therapeutics LCTX
Common Shares
Directly49,560,992$0.82$40.6M4.4%Form 4, Jan 27, 2025
Lineage Cell Therapeutics LCTX
Common Shares
Indirectly (see filing footnote)49,560,992$0.82$40.6M4.4%Form 4, Jan 27, 2025
Insight Molecular Diagnostics IMDX
Common Stock, no par value
Indirectly (see filing footnote)12,114,700$1.66$20.1M2.2%Form 4, Apr 20, 2026
Insight Molecular Diagnostics IMDX
Common Stock, no par value
Directly12,114,700$1.66$20.1M2.2%Form 4, Apr 20, 2026

Share counts are the amounts Broadwood Capital INC reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Broadwood Capital INC's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
STAAR Surgical STAA
Common Stock
Through Broadwood Partners, L.P.
Held by a company or fund the insider manages
15,508,393$25.03$388M—Form 4, Mar 11, 2026
Insight Molecular Diagnostics IMDX
Common Stock, no par value
Through Broadwood Partners, L.P.
Held by a company or fund the insider manages
12,033,896$1.66$20.0M—Form 4, Apr 16, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Apr 20, 2026BoughtIMDX40,690$3.88$158KView
Apr 17, 2026BoughtIMDX40,114$3.57$143KView
Apr 16, 2026BoughtIMDX102,057$3.45$352KView
Mar 13, 2026BoughtSTAA316,017$18.62$5.9MView
Mar 12, 2026BoughtSTAA299,432$18.12$5.4MView
Mar 11, 2026BoughtSTAA54,764$17.52$959KView
Feb 10, 2026BoughtIMDX521,739$5.75$3.0MView
Jan 9, 2026BoughtSTAA27,485$22.05$606KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
180Adolph Coors CO LLC
10% owner, Molson Coors Beverage
$956M−$23.1M (−2.36%)
181Two Sigma Management, LLC
10% owner, Hamilton Insurance Group
$943M−$13.2M (−1.38%)
182Atlas Venture Associates Opportunity I, L.P.
10% owner, Kymera Therapeutics
$932M−$15.3M (−1.61%)
183Broadwood Capital INC
10% owner, STAAR Surgical
$929M−$10.5M (−1.11%)
184Teacher Retirement System OF Texas
Insider, Life Time Group Holdings
$928M−$22.0M (−2.31%)
185ASP Amentum Investco LP
10% owner, Amentum Holdings
$923M+$4.0M (+0.43%)
186JAB Beauty B.V.
10% owner, Coty
$915M−$36.1M (−3.80%)

Other STAAR Surgical insiders

All STAA insiders

Questions

How much stock does Broadwood Capital INC own?

Broadwood Capital INC holds $928,660,361 in listed stock based on SEC filings and current prices, mostly STAAR Surgical (STAA). That ranks 183rd on the Stock Rich List.

Is this Broadwood Capital INC's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Broadwood Capital INC last buy or sell stock?

The most recent open-market trade on file is a purchase of 40,690 IMDX shares on Apr 20, 2026 at $3.88.

Files jointly with SEC filer 1278388.